TCRT Research and Charts

TCRT - Alaunos Therapeutics Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-12 (Delayed quote data 2025-09-15)

Last 2.25	Change ⇓ -0.06 (-2.60%)	Volume 42,825
	Open 2.29	High 2.40	Low 2.22

8EMA (Daily) 2.25	40EMA (Daily) 2.51	50EMA (Daily) 2.60	STO (Daily) 60.041	MACD Hist (Daily) 0.116
8EMA (Weekly) 2.417	40EMA (Weekly) 2.56	50EMA (Weekly) 2.47	STO (Weekly) 10.022	MACD Hist (Weekly) -0.336


Company Profile
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens (neoAg) arising from genomic mutations.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.